310 related articles for article (PubMed ID: 26362726)
1. First-trimester biochemical markers of placentation in screening for gestational diabetes mellitus.
Syngelaki A; Kotecha R; Pastides A; Wright A; Nicolaides KH
Metabolism; 2015 Nov; 64(11):1485-9. PubMed ID: 26362726
[TBL] [Abstract][Full Text] [Related]
2. First trimester screening for gestational diabetes mellitus by maternal factors and markers of inflammation.
Syngelaki A; Visser GH; Krithinakis K; Wright A; Nicolaides KH
Metabolism; 2016 Mar; 65(3):131-7. PubMed ID: 26892524
[TBL] [Abstract][Full Text] [Related]
3. First trimester maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus.
Savvidou MD; Syngelaki A; Muhaisen M; Emelyanenko E; Nicolaides KH
BJOG; 2012 Mar; 119(4):410-6. PubMed ID: 22324916
[TBL] [Abstract][Full Text] [Related]
4. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Hoopmann M; Abele H; Alkier R; Lüthgens K
Ultrasound Obstet Gynecol; 2012 Nov; 40(5):530-5. PubMed ID: 22611005
[TBL] [Abstract][Full Text] [Related]
5. Elevated placental growth factor concentrations at 11-14 weeks of gestation to predict gestational diabetes mellitus.
Eleftheriades M; Papastefanou I; Lambrinoudaki I; Kappou D; Lavranos D; Akalestos A; Souka AP; Pervanidou P; Hassiakos D; Chrousos GP
Metabolism; 2014 Nov; 63(11):1419-25. PubMed ID: 25173717
[TBL] [Abstract][Full Text] [Related]
6. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
Bakalis S; Gallo DM; Mendez O; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Aug; 46(2):208-15. PubMed ID: 25826797
[TBL] [Abstract][Full Text] [Related]
7. Maternal Diabetes, Large-for-Gestational-Age Births, and First Trimester Pregnancy-Associated Plasma Protein-A.
Wells G; Bleicher K; Han X; McShane M; Chan YF; Bartlett A; White C; Lau SM
J Clin Endocrinol Metab; 2015 Jun; 100(6):2372-9. PubMed ID: 25825946
[TBL] [Abstract][Full Text] [Related]
8. A first trimester prediction model for gestational diabetes utilizing aneuploidy and pre-eclampsia screening markers.
Sweeting AN; Wong J; Appelblom H; Ross GP; Kouru H; Williams PF; Sairanen M; Hyett JA
J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2122-2130. PubMed ID: 28562122
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
[TBL] [Abstract][Full Text] [Related]
10. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia.
Vandenberghe G; Mensink I; Twisk JW; Blankenstein MA; Heijboer AC; van Vugt JM
Prenat Diagn; 2011 Oct; 31(10):955-61. PubMed ID: 21717483
[TBL] [Abstract][Full Text] [Related]
11. Impaired placentation in women with chronic hypertension who develop pre-eclampsia.
Panaitescu AM; Akolekar R; Kametas N; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Oct; 50(4):496-500. PubMed ID: 28470791
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation.
Poon LC; Zaragoza E; Akolekar R; Anagnostopoulos E; Nicolaides KH
Prenat Diagn; 2008 Dec; 28(12):1110-5. PubMed ID: 19003787
[TBL] [Abstract][Full Text] [Related]
13. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Tsiakkas A; Duvdevani N; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 May; 45(5):591-8. PubMed ID: 25653039
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies.
Zaragoza E; Akolekar R; Poon LC; Pepes S; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Apr; 33(4):382-6. PubMed ID: 19277983
[TBL] [Abstract][Full Text] [Related]
15. A First-Trimester Biomarker Panel for Predicting the Development of Gestational Diabetes.
Farina A; Eklund E; Bernabini D; Paladino M; Righetti F; Monti G; Lambert-Messerlian G
Reprod Sci; 2017 Jun; 24(6):954-959. PubMed ID: 27837083
[TBL] [Abstract][Full Text] [Related]
16. Early first-trimester maternal serum placental growth factor in trisomy 21 pregnancies.
Cowans NJ; Stamatopoulou A; Tørring N; Spencer K
Ultrasound Obstet Gynecol; 2011 May; 37(5):515-9. PubMed ID: 21105022
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum placental growth factor, pregnancy-associated plasma protein-a and free β-human chorionic gonadotrophin at 30-33 weeks in the prediction of pre-eclampsia.
Lai J; Pinas A; Poon LC; Agathokleous M; Nicolaides KH
Fetal Diagn Ther; 2013; 33(3):164-72. PubMed ID: 23445908
[TBL] [Abstract][Full Text] [Related]
18. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia.
Wortelboer EJ; Koster MP; Cuckle HS; Stoutenbeek PH; Schielen PC; Visser GH
BJOG; 2010 Oct; 117(11):1384-9. PubMed ID: 20840693
[TBL] [Abstract][Full Text] [Related]
19. Prediction of spontaneous preterm birth and preterm prelabor rupture of membranes using maternal factors, obstetric history and biomarkers of placental function at 11-13 weeks.
Chiu CPH; Feng Q; Chaemsaithong P; Sahota DS; Lau YY; Yeung YK; Yim LW; Chung JPW; Poon LC
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):192-199. PubMed ID: 35445767
[TBL] [Abstract][Full Text] [Related]
20. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
Yu J; Shixia CZ; Wu Y; Duan T
Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
